[HTML][HTML] Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: a systematic review and meta …
T Yanagisawa, T Kawada, P Rajwa, H Mostafaei… - … Oncology: Seminars and …, 2023 - Elsevier
Background Cabazitaxel is an effective treatment of post-docetaxel metastatic castration-
resistant prostate cancer (mCRPC). We aimed to assess the sequencing impact and identify …
resistant prostate cancer (mCRPC). We aimed to assess the sequencing impact and identify …
[HTML][HTML] Docsubty: SSUA review on trends in development and translation of omics signatures in cancer
W Ma, W Tang, JSL Kwok, AHY Tong, CWS Lo… - Computational and …, 2024 - Elsevier
The field of cancer genomics and transcriptomics has evolved from targeted profiling to swift
sequencing of individual tumor genome and transcriptome. The steady growth in genome …
sequencing of individual tumor genome and transcriptome. The steady growth in genome …
Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma
S Hong, B Lin, M Xu, Q Zhang, Z Huo, M Su, C Ma… - …, 2023 - thelancet.com
Summary Background Cell-free DNA (cfDNA) is being explored as biomarker for non-
invasive diagnosis of cancer. We aimed to establish a cfDNA-based DNA methylation …
invasive diagnosis of cancer. We aimed to establish a cfDNA-based DNA methylation …
Recent advances in understanding DNA methylation of prostate cancer
HJ Shin, JT Hua, H Li - Frontiers in Oncology, 2023 - frontiersin.org
Epigenetic modifications, such as DNA methylation, is widely studied in cancer. DNA
methylation patterns have been shown to distinguish between benign and malignant tumors …
methylation patterns have been shown to distinguish between benign and malignant tumors …
Circulating tumor DNA biomarkers for response assessment in prostate cancer
O Sartor - Clinical Cancer Research, 2023 - AACR
Circulating tumor DNA (ctDNA) is measurable in the majority of metastatic castration-
resistant prostate cancer patients. Data indicate that ctDNA present at baseline can serve as …
resistant prostate cancer patients. Data indicate that ctDNA present at baseline can serve as …
Current Challenges of Methylation-Based Liquid Biopsies in Cancer Diagnostics
In current clinical practice, effective cancer testing and screening paradigms are limited to
specific types of cancer, exhibiting varying efficiency, acceptance, and adherence. Cell-free …
specific types of cancer, exhibiting varying efficiency, acceptance, and adherence. Cell-free …
[HTML][HTML] Prostate Cancer Tissue-Based Biomarkers
RI Anu, S Shamsudeen, SW Leslie - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Prostate Cancer Tissue-Based Biomarkers - StatPearls - NCBI Bookshelf US flag An official
website of the United States government Here's how you know NIH NLM Logo Access keys …
website of the United States government Here's how you know NIH NLM Logo Access keys …
[HTML][HTML] Cell-free DNA in the management of prostate cancer: Current status and future prospective
W He, Y Xiao, S Yan, Y Zhu, S Ren - Asian Journal of Urology, 2023 - Elsevier
Objective With the escalating prevalence of prostate cancer (PCa) in China, there is an
urgent demand for novel diagnostic and therapeutic approaches. Extensive investigations …
urgent demand for novel diagnostic and therapeutic approaches. Extensive investigations …
Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective …
Functional imaging with prostate-specific membrane antigen (PSMA) ligands has emerged
as the standard imaging method for prostate cancer (PCA). In parallel, the analysis of blood …
as the standard imaging method for prostate cancer (PCA). In parallel, the analysis of blood …
Identification and Localization of Indolent and Aggressive Prostate Cancers Using Multilevel Bi-LSTM
AM Alhassan - Journal of Imaging Informatics in Medicine, 2024 - Springer
Identifying indolent and aggressive prostate cancers is a critical problem for optimal
treatment. The existing approaches of prostate cancer detection are facing challenges as the …
treatment. The existing approaches of prostate cancer detection are facing challenges as the …